Literature DB >> 10783390

RGS4 is arginylated and degraded by the N-end rule pathway in vitro.

I V Davydov1, A Varshavsky.   

Abstract

The N-end rule relates the in vivo half-life of a protein to the identity of its N-terminal residue. We used an expression-cloning screen to search for mouse proteins that are degraded by the ubiquitin/proteasome-dependent N-end rule pathway in a reticulocyte lysate. One substrate thus identified was RGS4, a member of the RGS family of GTPase-activating proteins that down-regulate specific G proteins. A determinant of the RGS4 degradation signal (degron) was located at the N terminus of RGS4, because converting cysteine 2 to either glycine, alanine, or valine completely stabilized RGS4. Radiochemical sequencing indicated that the N-terminal methionine of the lysate-produced RGS4 was replaced with arginine. Since N-terminal arginine is a destabilizing residue not encoded by RGS4 mRNA, we conclude that the degron of RGS4 is generated through the removal of N-terminal methionine and enzymatic arginylation of the resulting N-terminal cysteine. RGS16, another member of the RGS family, was also found to be an N-end rule substrate. RGS4 that was transiently expressed in mouse L cells was short-lived in these cells. However, the targeting of RGS4 for degradation in this in vivo setting involved primarily another degron, because N-terminal variants of RGS4 that were stable in reticulocyte lysate remained unstable in L cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10783390     DOI: 10.1074/jbc.M001605200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Gamma 2 subunit of G protein heterotrimer is an N-end rule ubiquitylation substrate.

Authors:  Maria H Hamilton; Lana A Cook; Theodore R McRackan; Kevin L Schey; John D Hildebrandt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-16       Impact factor: 11.205

2.  Arginyltransferase is an ATP-independent self-regulating enzyme that forms distinct functional complexes in vivo.

Authors:  Junling Wang; Xuemei Han; Sougata Saha; Tao Xu; Reena Rai; Fangliang Zhang; Yuri I Wolf; Alexey Wolfson; John R Yates; Anna Kashina
Journal:  Chem Biol       Date:  2011-01-28

Review 3.  The N-end rule pathway: emerging functions and molecular principles of substrate recognition.

Authors:  Shashikanth M Sriram; Bo Yeon Kim; Yong Tae Kwon
Journal:  Nat Rev Mol Cell Biol       Date:  2011-10-21       Impact factor: 94.444

4.  Small molecule inhibitors of arginyltransferase regulate arginylation-dependent protein degradation, cell motility, and angiogenesis.

Authors:  Sougata Saha; Junling Wang; Brian Buckley; Qingqing Wang; Brenda Lilly; Mikhail Chernov; Anna Kashina
Journal:  Biochem Pharmacol       Date:  2012-01-18       Impact factor: 5.858

5.  DHHC protein-dependent palmitoylation protects regulator of G-protein signaling 4 from proteasome degradation.

Authors:  Jincheng Wang; Yan Xie; Dennis W Wolff; Peter W Abel; Yaping Tu
Journal:  FEBS Lett       Date:  2010-10-28       Impact factor: 4.124

6.  Identification of mammalian arginyltransferases that modify a specific subset of protein substrates.

Authors:  Reena Rai; Anna Kashina
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-07       Impact factor: 11.205

7.  Phosphorylation of RGS13 by the cyclic AMP-dependent protein kinase inhibits RGS13 degradation.

Authors:  Zhihui Xie; Zhao Yang; Kirk M Druey
Journal:  J Mol Cell Biol       Date:  2010-10-25       Impact factor: 6.216

8.  Killing of macrophages by anthrax lethal toxin: involvement of the N-end rule pathway.

Authors:  Katherine E Wickliffe; Stephen H Leppla; Mahtab Moayeri
Journal:  Cell Microbiol       Date:  2008-02-05       Impact factor: 3.715

9.  Discovery of cellular regulation by protein degradation.

Authors:  Alexander Varshavsky
Journal:  J Biol Chem       Date:  2008-08-15       Impact factor: 5.157

10.  NO triggers RGS4 degradation to coordinate angiogenesis and cardiomyocyte growth.

Authors:  Irina M Jaba; Zhen W Zhuang; Na Li; Yifeng Jiang; Kathleen A Martin; Albert J Sinusas; Xenophon Papademetris; Michael Simons; William C Sessa; Lawrence H Young; Daniela Tirziu
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.